High-dose interleukin-2 therapy for metastatic renal cell carcinoma: a contemporary experience.
Hanzly M, Aboumohamed A, Yarlagadda N, Creighton T, Digiorgio L, Fredrick A, Rao G, Mehedint D, George S, Attwood K, Kauffman E, Narashima D, Khushalani NI, Pili R, Schwaab T.
Hanzly M, et al. Among authors: digiorgio l.
Urology. 2014 May;83(5):1129-34. doi: 10.1016/j.urology.2014.02.005.
Urology. 2014.
PMID: 24767525